Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 32

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00957242Phase 3Terminated
AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis
Principalinvestigator

Research Network

Collaboration Network

32 collaborators·79 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

St. Luke's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Zhaohui Zhu, MD

Peking Union Medical College Hospital

Moderately Similar
19 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis
Similarity Score30%

Jesse Roman, MD

Emory University

Related
3 trials

Shared therapeutic areas:

Pulmonary FibrosisIdiopathic Pulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Lake Morrison, MD

Duke University

Related
2 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Gail Weinmann, MD

National Heart, Lung, and Blood Institute (NHLBI)

Related
2 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Ganesh Raghu, MD

University of Washington

Related
5 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Jay Ryu, MD

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Pulmonary FibrosisIdiopathic Pulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Milton Rossman, MD

University of Pennsylvania

Related
2 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Steven Sahn, MD

Medical University of South Carolina

Related
2 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Joao deAndrade, MD

University of Alabama at Birmingham

Related
2 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Jeffrey Chapman, MD

The Cleveland Clinic

Related
2 trials

Shared therapeutic areas:

Idiopathic Pulmonary FibrosisPulmonary Fibrosis

Worked with same sponsors:

Duke Clinical Research InstituteDuke University+1 more
Collaborated on 2 trials
Similarity Score28%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00650091Phase 3PrincipalInvestigator

Evaluating the Effectiveness of Prednisone, Azathioprine, and N-acetylcysteine in Patients With IPF

Pulmonary Fibrosis
Completed
NCT00957242Phase 3PrincipalInvestigator

AntiCoagulant Effectiveness in Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis
Terminated

All 2 trials loaded